Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - phenylbutazone; sodium salicylate - parenteral liquid/solution/suspension - phenylbutazone analgesic active 186.0 mg/ml; sodium salicylate phenol active 50.0 mg/ml - musculoskeletal system - dog | horse | horse foal | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses - analgesic | anti-inflammatory agent | musculoskeletal conditions | antipyretic | arthritis | arthrosis | bone soreness | bruising | bursitis | colic | external myopathy | inflamation of soft tissues an | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteitis | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon and ligament sprains | tendon sprains | tendonitis | tenosynovitis | traumatic joint and connective | traumatic swelling

United States - English - NLM (National Library of Medicine)

akorn - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride 25 mg in 1 ml - phenylephrine hydrochloride ophthalmic solution, usp 2.5% and 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, caution should be exercised when phenylephrine hydrochloride ophthalmic solution 2.5% and 10% is administered to a nursing woman. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age [see contraindications (4.2) ]. no overall differences in safety and effectiveness have been observed between elderly and younger adult patients.

United States - English - NLM (National Library of Medicine)

mwi/vetone - phenylbutazone (unii: gn5p7k3t8s) (phenylbutazone - unii:gn5p7k3t8s) - phenylbutazone 200 mg in 1 ml - for relief of inflammatory conditions associated with the musculoskeletal system in horses. treated animals should not be slaughtered for food purposes. parenteral injections should be made intravenously only; do not inject subcutaneously or intramuscularly. use with caution in patients who have a history of drug allergy. for relief of inflammatory conditions associated with the musculoskeletal system in horses. intravenous dosage (not subcutaneous or intramuscular use) : horses : 1 to 2 g per 1,000 lb body weight (5 to 10 ml/1,000 lb) daily. not for use in horses intended for food. see package outsert for additional information. approved by fda under anada # 200-371 each ml contains:  phenylbutazone ............................. 200 mg benzyl alcohol preservative .........10.45 mg sodium hydroxide to adjust ph to 9.5 to 10.0 water for injection ...............................q.s. 

United States - English - NLM (National Library of Medicine)

vet one - phenylbutazone (unii: gn5p7k3t8s) (phenylbutazone - unii:gn5p7k3t8s) - phenylbutazone 1 g in 3.027 g - actions and uses: kuzell (1,2,3), payne (4), flemming (5) and denko (6), demonstrated clinical effectiveness of phenylbutazone in acute rheumatism, gout, gouty arthritis and various other rheumatoid diseases in man.  anti-inflammatory activity has been well established by fabre (7), domenjoz (8), wilhelmi (9), and yourish (10). lieberman (11) reported on the effective use of phenylbutazone in the treatment of conditions of the musculoskeletal system in dogs, including posterior paralysis associated with intervertebral disc syndrome, fractures, arthritis and injuries to the limbs and joints.  joshua (12) observed objective improvement without toxicity following long-term therapy of two aged arthritic dogs.  ogilvie and sutter (13) reported rapid response to phenylbutazone therapy in a review of 19 clinical cases including posterior paralysis, posterior weakness, arthritis, rheumatism and other conditions associated with lameness and musculoskeletal weakness.  camberos (14) reported favorable results with pheny

United States - English - NLM (National Library of Medicine)

aspen veterinary resources, ltd. - phenylbutazone (unii: gn5p7k3t8s) (phenylbutazone - unii:gn5p7k3t8s) - phenylbutazone 200 mg in 1 ml - for relief of inflammatory conditions associated with the musculoskeletal system in horses. treated animals should not be slaughtered for food purposes. parenteral injections should be made intravenously only; do not inject subcutaneously or intramuscularly. use with caution in patients who have a history of drug allergy.

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - phenylephrine hydrochloride, quantity: 0.1 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia. it is also employed to overcome paroxysmal supraventricular tachycardia.

Malta - English - Medicines Authority

laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - phenylephrine hydrochloride - solution for injection in a pre-filled syringe - phenylephrine hydrochloride 50 µg/ml - cardiac therapy

Israel - English - Ministry of Health

cts ltd - phenylephrine hydrochloride - solution for injection / infusion - phenylephrine hydrochloride 10 mg / 1 ml - phenylephrine - for the treatment of hypotensive states, e.g. septic shock, circulatory failure, during spinal anaesthesia or drug-induced hypotension.

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - phenylephrine hydrochloride - solution for injection/infusion - 100 microgram(s)/millilitre - phenylephrine

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - phenylephrine hydrochloride - solution for injection/infusion - phenylephrine